Arkolith/Insider Trading/EBS/Form 4

Papa Joseph C

President and CEO, DirectorEmergent BioSolutions Inc. (EBS) · full profile →Form 4 · filed May 15, 2025
Net Buying
Open-Market Buys
$350K
Open-Market Sells
$0
Net Open-Market Flow
$350K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2025Buy(P)60K$5.83$350K343K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001367644-25-000127) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML